hims semaglutide shortage and Hers likely to stop selling cheaper versions of GLP-1 medications FDA says shortage of Ozempic

GLP-1 adoption has skyrocketed as a result

Tirzepatide works on two different mechanisms in the body to do a very similar thingmake you feel fuller. The key differences include: Semaglutide (Ozempic/Wegovy) works through one mechanism and was first to market Tirzepatide (Mounjaro) works through two mechanisms, potentially offering better weight loss results with fewer side effects Tirzepatide tends to be more expensive and less likely to be covered by insurance Semaglutides patent has expired, allowing compounding pharmacies to continue producing it regardless of FDA decisions This distinction explains why compounding pharmacies can continue offering semaglutide while tirzepatide remains in regulatory limbo

This is one of the known Ozempic side effects related to how the body metabolizes Semaglutide

Related clinical activity includes combination studies of YP05002 with its phase II-active glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist PF-07976016, alongside other small molecules

However, your doctor should monitor your blood pressure regularly because weight loss from semaglutide may reduce your need for blood pressure medication, requiring dose adjustments to avoid hypotension